Congress·In Committee·8 months ago
House Bill Would Expand Medicare Coverage for Obesity Drugs and Counseling
Also known as: Treat and Reduce Obesity Act of 2025
Legislative Progress
Impacts
Positive Impacts(3)
Key Points
Milestones
2 milestones2 actions
What Happens Next
Projected impacts based on AI analysis
Related News
2 articlesWill Medicare and Medicaid Cover Obesity Drugs?
Bipartisan legislation like the Treat and Reduce Obesity Act seeks to allow Medicare coverage for FDA-approved obesity medications and visits with specialists, potentially saving the system billions by reducing chronic disease complications.
C=
Medicare Opens Path to Covering Popular Weight Loss Drugs Under New Voluntary Program
CMS announced the BALANCE program, a voluntary model allowing Medicare beneficiaries to access GLP-1 medications for $50 a month, addressing the same access gaps targeted by the Treat and Reduce Obesity Act of 2025.
C+